13 / 38
STAMPEDE: ADT + Abiraterone + Prednisonole vs ADT alone in
mHSPC
James ND, et al. N Engl J Med. 2017;377:338-351; Hoyle A, ESMO 2018
•
Randomized, open-label, multiarm, multistage phase II/III trial (N = 1917)
•
Confirms LATITUDE in
HIGH RISK M1